SMMT · Summit Therapeutics Inc.
$12.79
+0.24 (+1.91%)
At close · Jul 29
Market Cap
$10.01B
Shares
797.75M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-23 | — | |
| 8-K | 2026-07-23 | — | |
| 10-Q | 2026-07-23 | 2026-06-30 | |
| 8-K | 2026-07-22 | — | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-12 | 2026-06-10 | |
| 8-K | 2026-06-11 | 2026-06-10 | |
| 8-K | 2026-06-03 | 2026-06-02 | |
| 8-K | 2026-06-01 | 2026-05-30 | |
| 10-Q | 2026-04-30 | 2026-03-31 | |
| 8-K | 2026-04-30 | — | |
| DEF 14A | 2026-04-17 | — | |
| 8-K | 2026-02-23 | — | |
| 10-K | 2026-02-23 | 2025-12-31 | |
| 8-K | 2026-01-29 | — | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-11-07 | — | |
| 8-K | 2025-10-22 | 2025-10-21 | |
| 10-Q | 2025-10-20 | 2025-09-30 | |
| 8-K | 2025-10-20 | 2025-10-17 | |
| 8-K | 2025-09-08 | 2025-09-07 | |
| 8-K | 2025-08-11 | — | |
| 10-Q | 2025-08-11 | 2025-06-30 | |
| 8-K | 2025-08-11 | — | |
| 8-K | 2025-06-20 | 2025-06-16 | |
| 8-K | 2025-06-17 | 2025-06-12 | |
| 8-K | 2025-05-30 | — | |
| 10-Q | 2025-05-01 | 2025-03-31 | |
| 8-K | 2025-05-01 | — | |
| DEF 14A | 2025-04-29 | 2025-06-12 | |
| 8-K | 2025-04-25 | — | |
| 8-K | 2025-04-23 | — | |
| 8-K | 2025-02-24 | — | |
| 10-K | 2025-02-24 | 2024-12-31 | |
| 8-K | 2025-01-24 | 2025-01-22 | |
| 8-K | 2025-01-13 | — | |
| 10-Q | 2024-10-30 | 2024-09-30 | |
| 8-K | 2024-10-30 | — | |
| 8-K | 2024-09-12 | 2024-09-11 | |
| 8-K | 2024-09-09 | 2024-09-08 | |
| 8-K | 2024-08-06 | — | |
| 10-Q | 2024-08-06 | 2024-06-30 | |
| 8-K | 2024-06-27 | — | |
| 8-K | 2024-06-17 | 2024-06-12 | |
| 8-K | 2024-06-03 | 2024-05-31 | |
| 8-K | 2024-06-03 | — | |
| 8-K | 2024-05-30 | — | |
| 8-K | 2024-05-24 | — | |
| 8-K | 2024-05-13 | — | |
| 8-K | 2024-05-01 | — |
Showing 1–50 of 176 filings
Key facts
CIK
1599298
CUSIP
86627T108
13F (30d)
33 filings
33 filers
Visit website
Investor relations